ARCHIVES

Advisors Call for External Oversight, Coordination of NCI Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 08 | February 25, 2005

Download PDF Visit The Full Archive

Related Articles

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

FDA Authority To Remove Paclitaxel Patent Questioned.

February 9, 2001

Maxine Singer Wins Top SES Award

January 8, 1988

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

New NCI Division Wins Approval To Fund Grants In Basic Biobehavioral Research

April 17, 1998